Equecabtagene Autoleucel
iaso biotherapeutics,innovent biologics
['multiple myeloma', '$ivbxf', 'iaso bio', 'innovent']
$ivbxf new article : innovent and iaso bio updated efficacy and safety clinical data of equecabtagene autoleucel (bcma car-t cell therapy) for multiple myeloma at the 2023 asco annual meeting 
Effortlessly track financial news and never miss an article again with https://t.co/hKE5DiO0B4. Our real-time database combines trusted financial news sources for easy access.